Zymeworks Earnings
NASDAQ: ZYMEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:39 PM ET
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$2.50
Zymeworks earnings summary
Zymeworks is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $2.50. In its most recent report on Aug 6, 2026 (Q2 2026), ZYME posted EPS of $-0.62. Revenue for the quarter was $4.6 million.
Quarterly EPS is down 2166.7% from the same quarter a year earlier. Across the last 16 reports, ZYME shares moved an average of 7.1% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
ZYME earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.62 | — | +6.7% |
| May 7, 2026 | — | $-0.59 | — | +0.2% |
| Jan 12, 2026 | — | $-0.55 | — | -1.0% |
| Nov 6, 2025 | — | $-0.26 | — | +12.5% |
| Aug 7, 2025 | — | $0.03 | — | +19.5% |
| May 8, 2025 | — | $-0.30 | — | +3.6% |
| Jan 8, 2025 | — | $-0.32 | — | +5.0% |
| Oct 31, 2024 | — | $-0.39 | — | +25.2% |
| Aug 1, 2024 | — | $-0.49 | — | -0.8% |
| May 2, 2024 | — | $-0.42 | — | -4.2% |
| Mar 6, 2024 | — | $-0.18 | — | -5.5% |
| Nov 7, 2023 | — | $-0.41 | — | +12.3% |
| Aug 10, 2023 | — | $-0.76 | — | +3.5% |
| May 8, 2023 | — | $-0.37 | — | -0.9% |
| Mar 7, 2023 | — | $4.78 | — | +5.4% |
| Nov 8, 2022 | — | $-0.72 | — | -7.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.